Tag Archive | "m& A"

Merck acquires Cubist Pharmaceuticals for $9.5bn

Tags: , , ,


Merck and Cubist Pharmaceuticals have entered into a definitive agreement under which Merck will acquire Cubist for $102 per share in cash, which represents a 35 percent premium to Cubist’s average stock price for the most recent five trading days. Read the full story

Current Agreements Deal Analysis Update : November 2014

Tags: , , ,


This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in October 2014. Read the full story

Top 50 pharma and biotech companies review – 2009 to 2014

Tags: , , , ,


The partnering and M&A  trends and deal analysis of the top 50 pharma and biotech companies reveals a flurry of data that is interesting to observe for efficient deal making. Read the full story

M&A news: Duke LifePoint Healthcare announces $500 million purchase

Tags: ,


M&A news: Duke LifePoint Healthcare announced today that it has signed a definitive agreement to acquire Conemaugh Health System Read the full story

Roche creates M&A headlines with Intermune purchase

Tags: , , ,


Roche announced the M&A of Brisbane, California biotech company InterMune, Inc. for a cash transaction totaling $8.3 billion Read the full story

Valeant extends the acquisition of Allergan

Tags: , ,


Valeant Pharmaceuticals has extended the acquisition period for Allergan. Read the full story

Big pharma, Valeant bids for a merger with Allergan

Tags: , , ,


Big Pharma, Valeant Pharmaceuticals International Team Up To Make $45.6 Billion Allergan Bid. Read the full story

M&A news: Servier agrees to buy shares in Egis

Tags: ,


French big pharma giant Servier has offered to buy the shares in Hungarian pharmaceuticals maker Egis creating M&A news Read the full story

Alere $241.5 million acquisition of Epocal

Tags: ,


Alere's recent acquisition of Epocal, a provider of best-in-class technologies that support blood gas and electrolyte testing at the point of care. Read the full story

M&A Deals: Bayer acquires Schiff Nutrition International for an agreed $1.2 billion

Tags: ,


Germany's Bayer, a top name in the pharma circle is set buy U.S. vitamins maker Schiff Nutrition International for an agreed $1.2 billion in a m&a agreement,  as it seeks stable sources of growth to complement its more volatile prescription drugs business Read the full story